ZFPM2
Zinc finger protein ZFPM2
Also known as: FOG2, FOG2_HUMAN, hFOG-2, ZC2HC11B, ZNF89B
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8WW38
- Gene
- ZFPM2
- Ensembl
- ENSG00000169946
- Chromosome
- 8
- Canonical length
- 1151 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
The zinc finger protein encoded by this gene is a widely expressed member of the FOG family of transcription factors. The family members modulate the activity of GATA family proteins, which are important regulators of hematopoiesis and cardiogenesis in mammals. It has been demonstrated that the protein can both activate and down-regulate expression of GATA-target genes, suggesting different modulation in different promoter contexts. A related mRNA suggests an alternatively spliced product but this information is not yet fully supported by the sequence. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
1151 residues, UniProt reviewed canonical sequence.
>Q8WW38|ZFPM2
1 MSRRKQSKPR QIKRPLEDAI EDEEEECPSE ETDIISKGDF PLEESFSTEF GPENLSCEEV
61 EYFCNKGDDE GIQETAESDG DTQSEKPGQP GVETDDWDGP GELEVFQKDG ERKIQSRQQL
121 PVGTTWGPFP GKMDLNNNSL KTKAQVPMVL TAGPKWLLDV TWQGVEDNKN NCIVYSKGGQ
181 LWCTTTKAIS EGEELIAFVV DFDSRLQAAS QMTLTEGMYP ARLLDSIQLL PQQAAMASIL
241 PTAIVNKDIF PCKSCGIWYR SERNLQAHLM YYCSGRQREA APVSEENEDS AHQISSLCPF
301 PQCTKSFSNA RALEMHLNSH SGVKMEEFLP PGASLKCTVC SYTADSVINF HQHLFSHLTQ
361 AAFRCNHCHF GFQTQRELLQ HQELHVPSGK LPRESDMEHS PSATEDSLQP ATDLLTRSEL
421 PQSQKAMQTK DASSDTELDK CEKKTQLFLT NQRPEIQPTT NKQSFSYTKI KSEPSSPRLA
481 SSPVQPNIGP SFPVGPFLSQ FSFPQDITMV PQASEILAKM SELVHRRLRH GSSSYPPVIY
541 SPLMPKGATC FECNITFNNL DNYLVHKKHY CSSRWQQMAK SPEFPSVSEK MPEALSPNTG
601 QTSINLLNPA AHSADPENPL LQTSCINSST VLDLIGPNGK GHDKDFSTQT KKLSTSSNND
661 DKINGKPVDV KNPSVPLVDG ESDPNKTTCE ACNITFSRHE TYMVHKQYYC ATRHDPPLKR
721 SASNKVPAMQ RTMRTRKRRK MYEMCLPEQE QRPPLVQQRF LDVANLNNPC TSTQEPTEGL
781 GECYHPRCDI FPGIVSKHLE TSLTINKCVP VSKCDTTHSS VSCLEMDVPI DLSKKCLSQS
841 ERTTTSPKRL LDYHECTVCK ISFNKVENYL AHKQNFCPVT AHQRNDLGQL DGKVFPNPES
901 ERNSPDVSYE RSIIKCEKNG NLKQPSPNGN LFSSHLATLQ GLKVFSEAAQ LIATKEENRH
961 LFLPQCLYPG AIKKAKGADQ LSPYYGIKPS DYISGSLVIH NTDIEQSRNA ENESPKGQAS
1021 SNGCAALKKD SLPLLPKNRG MVIVNGGLKQ DERPAANPQQ ENISQNPQHE DDHKSPSWIS
1081 ENPLAANENV SPGIPSAEEQ LSSIAKGVNG SSQAPTSGKY CRLCDIQFNN LSNFITHKKF
1141 YCSSHAAEHV KLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ZFPM2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.6
- Highest tissue expression
- 32 nTPM
Expression across tissuesHPA
Tissue
- ovary: 32 nTPM
- cerebellum: 28 nTPM
- skeletal muscle: 17 nTPM
- smooth muscle: 17 nTPM
- tongue: 16 nTPM
- fallopian tube: 12 nTPM
Single-cell type
- mesothelial cells: 2,530 nCPM
- fibro-adipogenic progenitors: 1,465 nCPM
- thymic myoid cells: 1,366 nCPM
- myonuclei: 1,277 nCPM
- brain excitatory neurons: 1,089 nCPM
- leydig cells: 918 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebellum: 141 nTPM
- hippocampal formation: 44 nTPM
- cerebral cortex: 36 nTPM
- pons: 36 nTPM
- amygdala: 25 nTPM
- thalamus: 23 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ZFPM2.
Disease | AllUniProt
Conditions ZFPM2 is implicated in, by any mechanism.
- Tetralogy of Fallot (TOF) MIM:187500
- Diaphragmatic hernia 3 (DIH3) MIM:610187
- 46,XY sex reversal 9 (SRXY9) MIM:616067
- Conotruncal heart malformations (CTHM) MIM:217095
Disease | GeneticClinVar
21 pathogenic / likely-pathogenic of 481 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Diaphragmatic hernia 3
- 46,XY sex reversal 9
- Double outlet right ventricle
- ZFPM2-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.14
- gnomAD pLI
- 1
- gnomAD missense Z
- 0.21
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell differentiation
- embryonic organ development
- fat cell differentiation
- gonadal mesoderm development
- heart development
- in utero embryonic development
- lung development
- negative regulation of DNA-templated transcription
- negative regulation of fat cell differentiation
- negative regulation of female gonad development
- negative regulation of transcription by RNA polymerase II
- outflow tract septum morphogenesis
- positive regulation of cardiac muscle cell proliferation
- positive regulation of male gonad development
- positive regulation of transcription by RNA polymerase II
- right ventricular cardiac muscle tissue morphogenesis
- vasculogenesis
- ventricular septum morphogenesis
Molecular functions
- DNA binding
- RNA polymerase II-specific DNA-binding transcription factor binding
- transcription coactivator activity
- transcription corepressor activity
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ZFPM2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ZFPM2 as an antibody target. Whether an autoantibody or antibody against ZFPM2 could matter depends on whether native ZFPM2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ZFPM2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ZFPM2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...